www.fdanews.com/articles/122958-basilea-8217-s-toctino-recommended-for-approval-in-15-additional-european-countries
Basilea’s Toctino Recommended for Approval in 15 Additional European Countries
December 14, 2009
Basilea Pharmaceutica Ltd. announces that Toctino
(alitretinoin) was recommended for regulatory approval under the Repeat-use Procedure in 13 additional European Union Member States as well as in Norway
and Iceland.
CNNMoney
CNNMoney